# Winmark Corp: financial statements, quarterly

WINA · Nasdaq · CIK 908315 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/wina.md) · [Financials](/companies/wina/financials.md) · [Filings](/companies/wina/filings.md) · [Insiders](/companies/wina/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wina/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.0 d](/filings/0000908315-26-000007.md) | [20.1](/filings/0000908315-25-000020.md) | [20.1](/filings/0000908315-25-000028.md) | [21.5](/filings/0000908315-25-000034.md) | [19.5 d](/filings/0000908315-26-000007.md) | [21.9](/filings/0000908315-26-000017.md) | [20.4](/filings/0000908315-26-000028.md) | [22.6](/filings/0000908315-26-000040.md) | [21.1 d](/filings/0000908315-26-000007.md) | [20.8](/filings/0000908315-26-000017.md) | [22.0](/filings/0000908315-26-000028.md) | [27.9](/filings/0000908315-26-000040.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [6.4 d](/filings/0000908315-26-000007.md) | [6.8](/filings/0000908315-25-000020.md) | [6.2](/filings/0000908315-25-000028.md) | [5.9](/filings/0000908315-25-000034.md) | [6.0 d](/filings/0000908315-26-000007.md) | [7.4](/filings/0000908315-26-000017.md) | [6.6](/filings/0000908315-26-000028.md) | [7.0](/filings/0000908315-26-000040.md) | [7.3 d](/filings/0000908315-26-000007.md) | [7.9](/filings/0000908315-26-000017.md) | [7.5](/filings/0000908315-26-000028.md) | [7.3](/filings/0000908315-26-000040.md) |
| Operating income | $m | [12.5 d](/filings/0000908315-26-000007.md) | [12.2](/filings/0000908315-25-000020.md) | [13.0](/filings/0000908315-25-000028.md) | [14.9](/filings/0000908315-25-000034.md) | [12.8 d](/filings/0000908315-26-000007.md) | [13.6](/filings/0000908315-26-000017.md) | [13.1](/filings/0000908315-26-000028.md) | [14.9](/filings/0000908315-26-000040.md) | [13.0 d](/filings/0000908315-26-000007.md) | [12.4](/filings/0000908315-26-000017.md) | [13.6](/filings/0000908315-26-000028.md) | [15.8](/filings/0000908315-26-000040.md) |
| Interest expense | $m | [0.8 d](/filings/0000908315-24-000010.md) | [0.7](/filings/0000908315-24-000023.md) | [0.7](/filings/0000908315-25-000028.md) | [0.7](/filings/0000908315-25-000034.md) | [0.7 d](/filings/0000908315-26-000007.md) | [0.6](/filings/0000908315-26-000017.md) | [0.6](/filings/0000908315-26-000028.md) | [0.6](/filings/0000908315-26-000040.md) | [0.6 d](/filings/0000908315-26-000007.md) | [0.6](/filings/0000908315-26-000017.md) | [0.6](/filings/0000908315-26-000028.md) | [0.6](/filings/0000908315-26-000040.md) |
| Income tax | $m | [2.4 d](/filings/0000908315-26-000007.md) | [2.8](/filings/0000908315-25-000020.md) | [2.1](/filings/0000908315-25-000028.md) | [3.5](/filings/0000908315-25-000034.md) | [2.8 d](/filings/0000908315-26-000007.md) | [3.2](/filings/0000908315-26-000017.md) | [2.1](/filings/0000908315-26-000028.md) | [3.5](/filings/0000908315-26-000040.md) | [2.7 d](/filings/0000908315-26-000007.md) | [2.6](/filings/0000908315-26-000017.md) | [2.8](/filings/0000908315-26-000028.md) | [3.6](/filings/0000908315-26-000040.md) |
| Net income | $m | [9.7 d](/filings/0000908315-26-000007.md) | [8.8](/filings/0000908315-25-000020.md) | [10.4](/filings/0000908315-25-000028.md) | [11.1](/filings/0000908315-25-000034.md) | [9.6 d](/filings/0000908315-26-000007.md) | [10.0](/filings/0000908315-26-000017.md) | [10.6](/filings/0000908315-26-000028.md) | [11.1](/filings/0000908315-26-000040.md) | [10.0 d](/filings/0000908315-26-000007.md) | [9.3](/filings/0000908315-26-000017.md) | [10.4](/filings/0000908315-26-000028.md) | [11.8](/filings/0000908315-26-000040.md) |
| Diluted EPS | $ per share | not reported | [2.41](/filings/0000908315-25-000020.md) | [2.85](/filings/0000908315-25-000028.md) | [3.03](/filings/0000908315-25-000034.md) | not reported | [2.71](/filings/0000908315-26-000017.md) | [2.89](/filings/0000908315-26-000028.md) | [3.02](/filings/0000908315-26-000040.md) | not reported | [2.50](/filings/0000908315-26-000017.md) | [2.81](/filings/0000908315-26-000028.md) | [3.21](/filings/0000908315-26-000040.md) |
| Basic EPS | $ per share | not reported | [2.52](/filings/0000908315-25-000020.md) | [2.97](/filings/0000908315-25-000028.md) | [3.16](/filings/0000908315-25-000034.md) | not reported | [2.81](/filings/0000908315-26-000017.md) | [3.00](/filings/0000908315-26-000028.md) | [3.13](/filings/0000908315-26-000040.md) | not reported | [2.59](/filings/0000908315-26-000017.md) | [2.90](/filings/0000908315-26-000028.md) | [3.29](/filings/0000908315-26-000040.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [13.4](/filings/0000908315-26-000007.md) | [22.9](/filings/0000908315-25-000020.md) | [29.4](/filings/0000908315-25-000028.md) | [37.2](/filings/0000908315-25-000034.md) | [12.2](/filings/0000908315-26-000007.md) | [21.8](/filings/0000908315-26-000017.md) | [28.8](/filings/0000908315-26-000028.md) | [39.7](/filings/0000908315-26-000040.md) | [10.3](/filings/0000908315-26-000040.md) | [19.8](/filings/0000908315-26-000017.md) | [25.8](/filings/0000908315-26-000028.md) | [28.0](/filings/0000908315-26-000040.md) |
| Current assets | $m | [16.7](/filings/0000908315-25-000010.md) | [26.3](/filings/0000908315-24-000023.md) | [33.0](/filings/0000908315-24-000031.md) | [40.5](/filings/0000908315-24-000035.md) | [15.4](/filings/0000908315-26-000007.md) | [25.8](/filings/0000908315-25-000020.md) | [32.2](/filings/0000908315-25-000028.md) | [43.1](/filings/0000908315-25-000034.md) | [14.1](/filings/0000908315-26-000040.md) | [25.1](/filings/0000908315-26-000017.md) | [30.8](/filings/0000908315-26-000028.md) | [32.6](/filings/0000908315-26-000040.md) |
| Total assets | $m | [29.0](/filings/0000908315-25-000010.md) | [38.3](/filings/0000908315-24-000023.md) | [44.7](/filings/0000908315-24-000031.md) | [52.0](/filings/0000908315-24-000035.md) | [26.8](/filings/0000908315-26-000007.md) | [37.1](/filings/0000908315-25-000020.md) | [43.2](/filings/0000908315-25-000028.md) | [53.7](/filings/0000908315-25-000034.md) | [24.9](/filings/0000908315-26-000040.md) | [35.6](/filings/0000908315-26-000017.md) | [43.2](/filings/0000908315-26-000028.md) | [45.0](/filings/0000908315-26-000040.md) |
| Current liabilities | $m | [10.5](/filings/0000908315-25-000010.md) | [14.4](/filings/0000908315-24-000023.md) | [11.5](/filings/0000908315-24-000031.md) | [10.5](/filings/0000908315-24-000035.md) | [5.1](/filings/0000908315-26-000007.md) | [9.7](/filings/0000908315-25-000020.md) | [7.0](/filings/0000908315-25-000028.md) | [7.2](/filings/0000908315-25-000034.md) | [5.7](/filings/0000908315-26-000040.md) | [9.1](/filings/0000908315-26-000017.md) | [8.2](/filings/0000908315-26-000028.md) | [10.2](/filings/0000908315-26-000040.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(59.2)](/filings/0000908315-26-000007.md) | [(52.6)](/filings/0000908315-25-000034.md) | [(42.2)](/filings/0000908315-25-000034.md) | [(33.7)](/filings/0000908315-25-000034.md) | [(51.0)](/filings/0000908315-26-000040.md) | [(45.9)](/filings/0000908315-26-000040.md) | [(36.8)](/filings/0000908315-26-000040.md) | [(26.3)](/filings/0000908315-26-000040.md) | [(53.7)](/filings/0000908315-26-000040.md) | [(46.2)](/filings/0000908315-26-000040.md) | [(37.6)](/filings/0000908315-26-000040.md) | [(37.4)](/filings/0000908315-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.8 d](/filings/0000908315-26-000007.md) | [13.4](/filings/0000908315-25-000020.md) | [8.2 d](/filings/0000908315-25-000028.md) | [12.1 d](/filings/0000908315-25-000034.md) | [8.5 d](/filings/0000908315-26-000007.md) | [15.1](/filings/0000908315-26-000017.md) | [9.0 d](/filings/0000908315-26-000028.md) | [12.3 d](/filings/0000908315-26-000040.md) | [8.5 d](/filings/0000908315-26-000007.md) | [11.9](/filings/0000908315-26-000017.md) | [10.7 d](/filings/0000908315-26-000028.md) | [12.9 d](/filings/0000908315-26-000040.md) |
| Capital expenditure | $m | [0.1 d](/filings/0000908315-26-000007.md) | [0.1](/filings/0000908315-25-000020.md) | [0.1 d](/filings/0000908315-25-000028.md) | [0.0 d](/filings/0000908315-25-000034.md) | [0.0 d](/filings/0000908315-26-000007.md) | [0.1](/filings/0000908315-26-000017.md) | [0.1 d](/filings/0000908315-26-000028.md) | [0.1 d](/filings/0000908315-26-000040.md) | [0.0 d](/filings/0000908315-26-000007.md) | [0.0](/filings/0000908315-26-000017.md) | [0.0 d](/filings/0000908315-26-000028.md) | [0.2 d](/filings/0000908315-26-000040.md) |
| Dividends paid | $m | [35.7 d](/filings/0000908315-26-000007.md) | [2.8](/filings/0000908315-25-000020.md) | [3.2 d](/filings/0000908315-25-000028.md) | [3.2 d](/filings/0000908315-25-000034.md) | [29.7 d](/filings/0000908315-26-000007.md) | [3.2](/filings/0000908315-26-000017.md) | [3.4 d](/filings/0000908315-26-000028.md) | [3.4 d](/filings/0000908315-26-000040.md) | [39.1 d](/filings/0000908315-26-000007.md) | [3.4](/filings/0000908315-26-000017.md) | [3.7 d](/filings/0000908315-26-000028.md) | [3.7 d](/filings/0000908315-26-000040.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [2.2](/filings/0000908315-26-000017.md) | [0.2 d](/filings/0000908315-26-000028.md) | [0.0 d](/filings/0000908315-26-000040.md) | [0.0 d](/filings/0000908315-26-000007.md) | not reported | not reported | [8.1](/filings/0000908315-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,594](/filings/0000908315-24-000023.md) | [3,635](/filings/0000908315-24-000031.md) | [3,654](/filings/0000908315-24-000035.md) | [3,661](/filings/0000908315-25-000020.md) | [3,657](/filings/0000908315-25-000028.md) | [3,671](/filings/0000908315-25-000034.md) | [3,673](/filings/0000908315-26-000017.md) | [3,673](/filings/0000908315-26-000028.md) | [3,693](/filings/0000908315-26-000040.md) | [3,709](/filings/0000908315-26-000017.md) | [3,696](/filings/0000908315-26-000028.md) | [3,686](/filings/0000908315-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,559,195 at 2026-10-12, from the cover of the [10-Q filed 2026-10-14](/filings/0000908315-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.